January 9, 2026

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating Through Challenges with Strategic Innovation

Emergent BioSolutions Inc. (NYSE: EBS) continues to stand out in the healthcare sector with its focused dedication to addressing some of the most critical public health threats. With a market..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring the 111% Upside Potential Amidst Strategic R&D

EyePoint, Inc. (NASDAQ: EYPT), a biotechnology firm with a focus on developing sustained delivery therapeutics for serious retinal diseases, has become a focal point for investors seeking high-growth potential within..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Strategic Focus in the Medical Device Sector

Surmodics, Inc. (NASDAQ: SRDX) stands at the forefront of the healthcare sector, specifically within the medical devices industry. With a market capitalization of $614.58 million, the company is a key..

Avanos Medical, Inc. (AVNS) Stock Analysis: Healthcare Innovator with 4.3% Revenue Growth and Strategic Market Position

Avanos Medical, Inc. (NYSE: AVNS) stands as a notable player in the healthcare sector, focusing on innovative medical device solutions. With a market capitalization of $569.1 million, Avanos is making..

Septerna, Inc. (SEPN) Stock Analysis: Unraveling a 28.76% Potential Upside in Biotechnology

For investors with an eye on the burgeoning biotechnology sector, Septerna, Inc. (SEPN) presents an intriguing opportunity. This clinical-stage company, headquartered in South San Francisco, California, is making significant strides..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unlocking a 41% Upside Potential

Investors are turning their focus to Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company that is gaining momentum in the healthcare sector. With a market capitalization of $5.46 billion, Cogent..

MeiraGTx Holdings (MGTX) Stock Report: Analyzing a 267% Upside Potential in the Biotech Sector

Investors with an eye on the biotechnology landscape might find MeiraGTx Holdings plc (NASDAQ: MGTX) a particularly intriguing opportunity. This clinical-stage genetics medicines company is making waves in the healthcare..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 29% Upside Potential in Healthcare Tech

Simulations Plus, Inc. (SLP), a notable player in the healthcare sector, has carved a niche within the health information services industry. Headquartered in Research Triangle Park, North Carolina, the company..

Investor Outlook on Personalis, Inc. (PSNL): Analyzing a Potential 31.34% Upside in the Genomics Sector

Personalis, Inc. (NASDAQ: PSNL) is charting a unique course in the burgeoning field of advanced cancer genomics, offering a suite of sophisticated diagnostic tests and services to detect and monitor..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Opportunities in the Senior Living Market

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector specializing in medical care facilities, presents a notable opportunity for investors interested in the senior housing market. Based..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 264% Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning name in the biotechnology sector, has been capturing significant investor attention due to its innovative approach in therapeutic protein and antibody development. Headquartered..

Myriad Genetics, Inc. (MYGN) Investor Outlook: A 23.78% Potential Upside Amidst Diagnostic Innovation

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at the forefront of the healthcare sector, specializing in diagnostics and research. As a molecular diagnostic testing and precision medicine company, Myriad Genetics offers..

Verastem, Inc. (VSTM) Investor Outlook: Biotech Stock with Over 100% Potential Upside

For investors with a keen interest in the biotechnology sector, Verastem, Inc. (NASDAQ: VSTM) presents a compelling proposition characterized by its focus on innovative cancer treatments. This development-stage biopharmaceutical company,..

AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem with Over 200% Upside Potential

AtaiBeckley Inc. (NASDAQ: ATAI) is capturing the attention of investors with its innovative approaches in the biotechnology sector, particularly in mental health treatments. The Netherlands-based company, with a market capitalization..

Cullinan Therapeutics, Inc. (CGEM)

⚠️ No article content returned.

..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

Abivax SA (ABVX) Stock Analysis: Exploring a 28.41% Upside in the Biotech Sector

In the dynamic world of biotechnology, Abivax SA (ABVX) stands out not only for its ambitious clinical trials but also for its potential to offer investors a significant upside. With..

Humacyte, Inc. (HUMA) Stock Analysis: Unveiling a Potential 571.55% Upside in the Biotech Sector

Humacyte, Inc. (NASDAQ: HUMA) is a pioneering biotechnology company that stands at the forefront of revolutionary advancements in the healthcare sector. With its proprietary technology platform focused on bioengineered human..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a 107% Potential Upside in the Biotech Sector

Investors with a keen eye on the biotechnology sector should keep REGENXBIO Inc. (NASDAQ: RGNX) on their radar. With a market capitalization of $759.35 million, this clinical-stage biotechnology company is..

Nuvation Bio Inc. (NUVB) Stock Analysis: 32.81% Potential Upside Sparks Investor Interest

Investors with an eye on the healthcare sector may find Nuvation Bio Inc. (NASDAQ: NUVB) an intriguing option. The clinical-stage biopharmaceutical company is making waves in the biotechnology industry with..

Search

Funds

January 9, 2026

Search

Funds

January 9, 2026

FTSE 100

Funds